RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINESА. Е. Каратеев, Н. В. Чичасова, S. S. Kopenkin et al.|Rheumatology Science and Practice|2018Cited by 151
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)Д. В. Буханова, С. И. Глухова, Б. С. Белов et al.|Meditsinskiy sovet = Medical Council|2019Cited by 14
Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)Е. Л. Насонов, Б. С. Белов, Z. N. Sukmarova et al.|Rheumatology Science and Practice|2023Cited by 12
INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSГ. М. Тарасова, Т. В. Попкова, Б. С. Белов et al.|Rheumatology Science and Practice|2018Cited by 7
FRI0212 USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPYGalina Tarasova, Т. В. Попкова, Б. С. Белов et al.|Annals of the Rheumatic Diseases|2019Cited by 7